Premier Research and Centogene have announced a strategic partnership to provide end-to-end support in rare disease clinical trials. The collaboration aims to improve patient identification, stratification, recruitment, and enrollment, thereby increasing the likelihood of study success.
Published first on TheFly
See Insiders’ Hot Stocks on TipRanks >>
Read More on CNTG:
- CENTOGENE Announces Its Attendance at the 41st Annual J.P. Morgan Healthcare Meeting and Fierce JPM Week in San Francisco
- CENTOGENE Reports Second Quarter and First Half 2022 Financial Results
- CENTOGENE Receives Nasdaq Non-Compliance Notice
- Centogene receives Nasdaq non-compliance notice
- CENTOGENE Announces Changes to Supervisory Board, Including Appointment of Mary Sheahan
